Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.
D000293:Adolescent; D000326:Adrenoleukodystrophy / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging; D002331:Carnitine / Q000627:therapeutic use*; D002994:Clofibrate / Q000627:therapeutic use*; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000628:therapy*; D005227:Fatty Acids / Q000097:blood*; D006801:Humans; D008297:Male; D014057:Tomography, X-Ray Computed
D005227:Fatty Acids; D002994:Clofibrate; D002331:Carnitine